Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Tak

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Biochemical Society Transactions|October 21, 2006
Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritisK A Reedquist, J Ludikhuize, P P Tak
Annals of the Rheumatic Diseases|April 15, 2004
Chemokines in joint disease: the key to inflammation?J J Haringman, J Ludikhuize, P P Tak
Annals of the Rheumatic Diseases|May 22, 2007
Rheumatoid arthritis in Dubai--delayed diagnosis and low usage of disease modifying antirheumatic drugsHumeira Badsha, K Ooi Kong, P P Tak
The Netherlands Journal of Medicine|October 8, 2011
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseasesZ Szekanecz, A E Koch, P P Tak
Autoimmunity Reviews|October 12, 2013
Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammationM I Ramos, P P Tak, M C Lebre
Annals of the Rheumatic Diseases|April 19, 2005
Cerebral vasculitis as a primary manifestation of systemic lupus erythematosusA T Rowshani, P Remans, A Rozemuller, et al.
Rheumatology (Oxford, England)|March 3, 2006
Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genesJ Adriaansen, M J B M Vervoordeldonk, P P Tak
The Netherlands Journal of Medicine|September 22, 2009
Where the immune response meets the vessel wallR J Bisoendial, E S G Stroes, P P Tak
Current Pharmaceutical Design|January 14, 2011
Critical determinants of cardiovascular risk in rheumatoid arthritisR J Bisoendial, E S G Stroes, P P Tak
Annals of the Rheumatic Diseases|June 30, 2000
Synovial biopsy in arthritis research: five years of concerted European collaborationB Bresnihan, P P Tak, P Emery, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Biochemical Society Transactions|October 21, 2006
Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritisK A Reedquist, J Ludikhuize, P P Tak
Annals of the Rheumatic Diseases|April 15, 2004
Chemokines in joint disease: the key to inflammation?J J Haringman, J Ludikhuize, P P Tak
Annals of the Rheumatic Diseases|May 22, 2007
Rheumatoid arthritis in Dubai--delayed diagnosis and low usage of disease modifying antirheumatic drugsHumeira Badsha, K Ooi Kong, P P Tak
The Netherlands Journal of Medicine|October 8, 2011
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseasesZ Szekanecz, A E Koch, P P Tak
Autoimmunity Reviews|October 12, 2013
Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammationM I Ramos, P P Tak, M C Lebre
Annals of the Rheumatic Diseases|April 19, 2005
Cerebral vasculitis as a primary manifestation of systemic lupus erythematosusA T Rowshani, P Remans, A Rozemuller, et al.
Rheumatology (Oxford, England)|March 3, 2006
Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genesJ Adriaansen, M J B M Vervoordeldonk, P P Tak
The Netherlands Journal of Medicine|September 22, 2009
Where the immune response meets the vessel wallR J Bisoendial, E S G Stroes, P P Tak
Current Pharmaceutical Design|January 14, 2011
Critical determinants of cardiovascular risk in rheumatoid arthritisR J Bisoendial, E S G Stroes, P P Tak
Annals of the Rheumatic Diseases|June 30, 2000
Synovial biopsy in arthritis research: five years of concerted European collaborationB Bresnihan, P P Tak, P Emery, et al.
Pageof 21